Zhang, J., Tan, B. & Fernandez-Pol, S. Lupus erythematosus cells in a bone marrow aspirate. J Hematopathol 16, 247–248 (2023). https://doi.org/10.1007/s12308-023-00561-8
ASH Abstract 2024: "Clinical Outcomes and Incidence of Immunophenotypic Switching from Primitive at Diagnosis to Monocytic at Relapse in AML Patients Treated with Venetoclax + Azacitidine Versus Intensive Chemotherapy."
ASH abstract 2024: "Venetoclax Plus Azacitidine for Newly Diagnosed Younger Acute Myeloid Leukemia Patients Independent of Fitness for Intensive Chemotherapy."
USCAP 2025 abstract: Prognostic Impact of Chromosome 7 Losses in High-Grade TP53 Mutated Myeloid Neoplasms
Wadsworth P, Zhang J, Miller T, Menke J, Oak J, Fernandez-Pol S. Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry. Leuk Lymphoma. 2024 Sep;65(9):1374-1377. PubMed PMID: 38747176
USCAP abstract: Assessment of Community Lead Exposure and Poisoning by Reviewing Medical Records of Patients with Measurable Level of Lead in Blood at an Academic Medical Center
USCAP 2025 abstract: A 4-Gene Co-Alteration Signature (SIG4) Predictive of Favorable Outcomes in High-Grade TP53 Mutated Myeloid Neoplasms: An International TP53 Investigators Network (iTIN) Study
Symes EO, Wang P, Sojitra P, Menon MP, Patel AA, Hasan F, Ghosh S, Roloff GW, Zhou Q, Findley A, Badar T, Zhang J, Tariq H, Chang H, Bell RC, Perry AM, Venkataraman G. Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms. Br J Haematol. 2024 Nov 17. [Epub ahead of print] PubMed PMID: 39551719
Zhou X, Zhang J. EBV-positive inflammatory follicular dendritic cell sarcoma, an entity by many names. Br J Haematol. 2024 Nov 19. [Epub ahead of print] PubMed PMID: 39562822